Missing rehab due to COVID-19 increased distress in women with breast cancer

September 28, 2020 – Beyond the tragic surges in hospitalizations and deaths, the first months of the COVID-19 pandemic disrupted healthcare for people with a wide range of medical conditions – including cancer. For women recovering after breast cancer treatment, COVID-19-related interruptions in rehabilitation care led to emotional distress and other effects on health and…

Cincinnati Children’s research helps pave way for newly approved use of drug

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children’s Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome. Hypereosinophilic syndrome, also known as HES, is a life-threatening group of blood disorders…